Botulinum neurotoxin formulations: overcoming the confusion [Corrigendum]
Samizadeh S, De Boulle K. Clin Cosmet Investig Dermatol. 2018;11:273–287.On page 273, Introduction section, line 5, the sentence “The human nervous system is susceptible to BoNT-A, B, C, E, F, and G and unaffected by D.1,4–6” should be changed to “Th...
Saved in:
Main Authors: | Samizadeh S (Author), De Boulle K (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2018-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Botulinum neurotoxin formulations: overcoming the confusion
by: Samizadeh S, et al.
Published: (2018) -
Comparison of botulinum neurotoxin type A formulations in Asia
by: Frevert J, et al.
Published: (2018) -
Botulinum Neurotoxins and Nervous System Future Challenges for Novel Indications
Published: (2020) -
Tyrosine Phosphorylation of Botulinum Neurotoxin Protease Domains
by: Stephen eToth, et al.
Published: (2012) -
Consensus Statement on the Use of Botulinum Neurotoxin in the Middle East
by: Ali S, et al.
Published: (2023)